RODGER CURRIE

Congressional outreach regarding biodefense medical countermeasures for smallpox. Reauthorization of the Pandemic and All-Hazards Preparedness Act (H.R. 2504 and S. 1855). FY2013 HHS/BARDA funding (Senate Labor-HHS Appropriations and House Labor-HHS Appropriations).

Medicare Part D; Medicare coverage policy for chronic renal disease; Medicare Part B reimbursement and coverage of dialysis products; Congressional deficit reduction negotiations and Deficit Reduction Commission, following passage of the Budget Control Act of 2011 (P.L. 112-25)

Implementation of P.L. 111-148, Patient Protection and Affordable Care Act and Implementation of P.L. 111-152, Health Care and Education Reconciliation Act (Biosimilars); (Independent Payment Advisory Board "IPAB"); Reauthorization of the Prescription Drug User Fee Act; Budget Control Act of 2011 (P.L. 112-25)

Medicare payment for Part B drugs and biologics Regulation of radiolabeled medical products

Medicare payment for Part B drugs and biologics Regulation of radiolabeled medical products

Implementation of Project BioShield Act and the Pandemic and All-Hazards Preparedness Act (PAHPA). Education and awareness on smallpox medical countermeasures (MCM).

H.R. 1249 America Invents Act of 2011; S. 23 Patent Reform Act of 2011

Expanding patient access to medical devices and products.

Legislative and regulatory matters affecting STEM education.

Medicare Part D; Medicare coverage policy for chronic renal disease; Medicare Part B reimbursement and coverage of dialysis products; Congressional deficit reduction negotiations and Deficit Reduction Commission, following passage of the Budget Control Act of 2011 (P.L. 112-25)

Implementation of P.L. 111-148, Patient Protection and Affordable Care Act and Implementation of P.L. 111-152, Health Care and Education Reconciliation Act (Biosimilars); (Independent Payment Advisory Board "IPAB"); Reauthorization of the Prescription Drug User Fee Act; Budget Control Act of 2011 (P.L. 112-25)

Expanding patient access to medical devices and products.

H.R. 1249 America Invents Act of 2011; S. 23 Patent Reform Act of 2011

Legislative and regulatory matters affecting STEM education.

Implementation of P.L. 111-148, Patient Protection and Affordable Care Act and Implementation of P.L. 111-152, Health Care and Education Reconciliation Act (Biosimilars); (Independent Payment Advisory Board "IPAB"); Reauthorization of the Prescription Drug User Fee Act; Budget Control Act of 2011 (P.L. 112-25)

Medicare Part D; Medicare coverage policy for chronic renal disease; Medicare Part B reimbursement and coverage of dialysis products; Congressional deficit reduction negotiations and Deficit Reduction Commission, following passage of the Budget Control Act of 2011 (P.L. 112-25)

Legislative and regulatory matters related to the Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS) with a focus on the regulation of novel therapeutics for the treatment of obesity.

Legislative and regulatory matters related to the Food and Drug Administration (FDA) with a focus on the regulation of novel therapeutics for the treatment of obesity.

Expanding patient access to medical devices and products.

H.R. 1249 America Invents Act of 2011; S. 23 Patent Reform Act of 2011.

Legislative and regulatory matters affecting STEM education.

S. 23 Patent Reform Act of 2011.

Implementation of P.L. 111-148, Patient Protection and Affordable Care Act and Implementation of P.L. 111-152, Health Care and Education Reconciliation Act (Biosimilars); (Independent Payment Advisory Board "IPAB"); Reauthorization of the Prescription Drug User Fee Act

Medicare Part D; Medicare coverage policy for chronic renal disease; Medicare Part B reimbursement and coverage of dialysis products; Congressional deficit reduction negotiations and Deficit Reduction Commission, following passage of the Budget Control Act of 2011 (P.L. 112-25)

Legislative and regulatory matters related to the Food and Drug Administration (FDA) with a focus on the regulation of novel therapeutics for the treatment of obesity.

Expanding patient access to medical devices and products.

Legislative and regulatory matters affecting STEM education.

H.R. 1249 America Invents Act of 2011; S. 23 Patent Reform Act of 2011.

Medicare Part D; Medicare coverage policy for chronic renal disease; Medicare Part B reimbursement and coverage of dialysis products.

Implementation of P.L. 111-148, Patient Protection and Affordable Care Act and Implementation of P.L. 111-152, Health Care and Education Reconciliation Act (Biosimilars); (Independent Payment Advisory Board "IPAB"); Reauthorization of the Prescription Drug User Fee Act

Implementation of P.L. 111-148, Patient Protection and Affordable Care Act and Implementation of P.L. 111-152, Health Care and Education Reconciliation Act (Biosimilars); (Independent Payment Advisory Board "IPAB")

H.R. 3082, Continuing Appropriations and Surface Transportation Extensions Act 2011 (Medicare Part D) (Medicare coverage policy for chronic renal disease); Medicare Part B reimbursement and coverage of dialysis products.

Legislative and regulatory matters related to the Food and Drug Administration (FDA) with a focus on the regulation of novel therapeutics for the treatment of obesity.

Expanding patient access to medical devices and products.

Expanding patient access to medical devices and products.

Legislative and regulatory matters related to the Food and Drug Administration (FDA) with a focus on the regulation of novel therapeutics for the treatment of obesity.